Hi all! As Tincup point out earlier in this thread, all of our study opportunities are announcements as opposed to endorsements. Please do your own research. That said, Sano Genetics asked me to update this research announcement; (see below.) If interested, please reach out to their trial screener here.
At least 50 million people worldwide are thought to be living with Alzheimer’s disease (the most common form of dementia). Although the biggest risk factor for Alzheimer’s is ageing, the disease is not a normal part of getting older and there are genetic factors at play in some cases.
The goal of this study is to help develop a potential new drug treatment for Alzheimer's disease (AD), which researchers think could be effective in treating AD in its early stages. The drug, ALZ-801, is being developed by Alzheon as a potential new treatment for slowing or stopping cognitive decline in some AD patients.
Eligible participants for the study will receive either the potential new treatment drug or a placebo. The study will also help researchers gather further information about the drug’s long-term safety.
Who can take part?
You, or the person you care for, must:
Be aged 50 to 80 years old
Have a clinical diagnosis of Alzheimer’s disease or mild cognitive impairment
Be willing to securely share DNA data
Be willing to have DNA data screened for the APOE4 homozygous genotype (NOTE: They are looking for homozygotes)
Be based in the United States or United Kingdom
Why take part?
If you qualify for and decide to join the APOLLOE4 study, you may receive at no cost:
Access to a study drug for 18 months that is designed to slow Alzheimer’s disease progression
Close care and monitoring from an Alzheimer’s disease specialist
Opportunity to help advance the treatment of Alzheimer’s disease
Reimbursement for study-related time and travel expenses
Safety and security
When you entrust your DNA Data and Personal Information to Sano Genetics, we commit to keeping them safe and secure. If you consent to participate, the Study Data will be stored by Sano Genetics on secure, encrypted, and wholly owned and secure servers (e.g. HIPAA compliant servers). Every part of Sano is built privacy-first and we use clear, transparent language to keep you informed
at every stage throughout the process.